Whole Food Plant-based Diet to Improve Outcomes in Prostate Cancer
NCT07220499 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 11
Last updated 2025-10-24
Summary
The purpose of this research is to determine if consuming a whole food plant-based diet for six months impacts outcomes in men with prostate cancer that have a rising prostate-specific antigen (PSA) level. The main questions it aims to answer are:
Does a whole-food plant-based impact PSA? Does a whole food plant-based diet impact risk factors associated with treatment for prostate cancer including LDL cholesterol, hemoglobin A1C, C-reactive protein?
Participants will be asked to attend twelve two-hour plant-based cooking and nutrition classes throughout a six-month period, consume a mostly whole food plant-based diet, provide blood samples, and complete three-day food journals to assess nutrient intake.
Conditions
Interventions
- OTHER
-
Whole Food Plant-based Diet
6-months of a predominately whole food plant-based diet
Sponsors & Collaborators
-
Pacific Cancer Care
lead OTHER
Principal Investigators
-
John Hausdorff, MD · Pacific Cancer Care
Study Design
- Allocation
- NA
- Purpose
- OTHER
- Masking
- NONE
- Model
- SINGLE_GROUP
Eligibility
- Min Age
- 45 Years
- Max Age
- 99 Years
- Sex
- MALE
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2023-11-07
- Primary Completion
- 2025-09-25
- Completion
- 2025-09-25
Countries
- United States
Study Locations
More Related Trials
-
Sulphate Accumulation in Prostate
NCT02821728 ·Status: COMPLETED ·Phase: NA
-
Efficacy of Natural Extract 2007RD01 Combined With Saw Palmetto in Benign Prostatic Hyperplasia Patients Compared to Saw Palmetto
NCT00797394 ·Status: COMPLETED ·Phase: PHASE2
-
Saw Palmetto Extract in Benign Prostatic Hyperplasia
NCT00037154 ·Status: COMPLETED ·Phase: PHASE3
-
The Effects of Lycopene on High Risk Prostatic Tissue
NCT01443026 ·Status: COMPLETED ·Phase: PHASE2
-
Use of Autologous Adipose-Derived Stem/Stromal Cells (AD-cSVF) in Symptomatic Benign Prostate Hypertrophy
NCT02961114 ·Status: WITHDRAWN ·Phase: PHASE1/PHASE2
-
Effects and Safety of OPK-88004 Doses in Men With Signs and Symptoms of Benign Prostatic Hyperplasia (BPH)
NCT03297398 ·Status: TERMINATED ·Phase: PHASE2
-
Efficacy of Prostatic Artery Embolization (PAE) in Patients With Severe Benign Prostatic Hyperplasia (BPH)
NCT02167919 ·Status: COMPLETED ·Phase: NA
-
Effect of Sulforaphane on Prostate CAncer PrEvention
NCT01950143 ·Status: COMPLETED ·Phase: NA
-
Urokinase Plasminogen Activator System in Benign Prostatic Hyperplasia
NCT00407329 ·Status: COMPLETED
-
Phase 4 Study of Greenlight XPS Laser Versus BiVAP Saline Vaporization of the Prostate in Men With Symptomatic Benign Prostatic Hyperplasia
NCT01500057 ·Status: COMPLETED ·Phase: PHASE4
-
Efficacy of Prostate Seed Implantation for Local Control of Early Stage Prostate Cancer
NCT00773305 ·Status: COMPLETED
-
Health Interventions in Men Undergoing Radical Prostatectomy
NCT01748110 ·Status: WITHDRAWN ·Phase: NA
-
Treatment Frequency and Satisfaction in Patients With Advanced Prostate Cancer
NCT01441713 ·Status: COMPLETED
-
Prostatic Artery Embolization (PAE) for Treatment of Benign Prostatic Hyperplasia (BPH)
NCT02026908 ·Status: COMPLETED ·Phase: NA
-
Effects of TNF Blockade on Human BPH/LUTS
NCT06062875 ·Status: RECRUITING ·Phase: PHASE2
-
Evaluation of PSA Blood Levels Prior to and After Digital Rectal Examination
NCT02747563 ·Status: UNKNOWN ·Phase: PHASE1
-
A Study to Evaluate the Effects of a Prostate Health Formulation
NCT02886832 ·Status: COMPLETED ·Phase: NA
-
(Phosphodiesterase 5 Inhibitors & α-blockers): Single Versus Combined Therapy in Benign Prostatic Hyperplasia
NCT05236634 ·Status: UNKNOWN ·Phase: NA
-
Clinical Trial in Males With BPH (Enlarged Prostate)
NCT00029822 ·Status: COMPLETED ·Phase: PHASE3
-
Open Randomized Clinical Trial to Evaluate the Effects of Intermittent Caloric Restriction in Patients With Lower Urinary Tract Symptoms Secondary to Benign Prostatic Hyperplasia.
NCT03669692 ·Status: WITHDRAWN ·Phase: NA
-
Prostatic Artery Embolization (PAE) for Treatment of Signs and Symptoms of Benign Prostatic Hyperplasia (BPH) Using Bead Block Microspheres
NCT03052049 ·Status: COMPLETED ·Phase: NA
-
Effects of Alpha Blockers on Prostate-specific Antigen (PSA) Change in Men With Lower Urinary Tract Symptoms (LUTS)
NCT01250483 ·Status: COMPLETED
-
ED Recovery in Men Age </=65 Treated With Bilateral Nerve Sparing Robotic Assisted Prostatectomy for Prostate Cancer
NCT00544076 ·Status: TERMINATED ·Phase: PHASE3
-
A Study in Men With Benign Prostatic Hyperplasia
NCT01097707 ·Status: TERMINATED ·Phase: PHASE2
-
Enhanced Clinical Decisions for Management of Benign Prostatic Hyperplasia Using Patient-Reported Outcomes
NCT05898932 ·Status: RECRUITING